1
|
Zhang J, Wang CH, Liu XJ, Cheng SF, Han LH, Lv CL. Efficacy and safety analysis of dopamine combined with creatine phosphate sodium in the treatment of infantile pneumonia combined with heart failure. J BIOL REG HOMEOS AG 2020; 34:2103-2108. [PMID: 33203205 DOI: 10.23812/20-300-l] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Affiliation(s)
- J Zhang
- Department of Pharmacy, Maternal and Child Health Care Hospital of Zhangqiu District, Jinan, China
| | - C H Wang
- Department of Pediatrics, the People's Hospital of Zhangqiu Area, Jinan, China
| | - X J Liu
- Department of Nursing, the People's Hospital of Zhangqiu Area, Jinan, China
| | - S F Cheng
- Department of Nephrology, the People's Hospital of Zhangqiu Area, Jinan, China
| | - L H Han
- Department of Health Examination, the People's Hospital of Zhangqiu Area, Jinan, China
| | - C L Lv
- Disinfection Supply Room, Weifang Traditional Chinese Hospital, Weifang, China
| |
Collapse
|
2
|
Cao X, Shang QH, Chi XL, Zhang W, Xiao HM, Sun MM, Chen G, An Y, Lv CL, Wang L, Nan YM, Chen CY, Tan ZN, Liu XE, Zhuang H. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus. World J Gastroenterol 2020; 26:1067-1079. [PMID: 32205997 PMCID: PMC7080998 DOI: 10.3748/wjg.v26.i10.1067] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Revised: 01/10/2020] [Accepted: 01/18/2020] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Hepatitis B virus (HBV) infection is the primary cause of hepatitis with chronic HBV infection, which may develop into liver fibrosis, cirrhosis and hepatocellular carcinoma. Detection of early-stage fibrosis related to HBV infection is of great clinical significance to block the progression of liver lesion. Direct liver biopsy is regarded as the gold standard to detect and assess fibrosis; however, this method is invasive and prone to clinical sampling error. In order to address these issues, we attempted to find more convenient and effective serum markers for detecting HBV-induced early-stage liver fibrosis.
AIM To investigate serum N-glycan profiling related to HBV-induced liver fibrosis and verify multiparameter diagnostic models related to serum N-glycan changes.
METHODS N-glycan profiles from the sera of 432 HBV-infected patients with liver fibrosis were analyzed. Significant changed N-glycan levels (peaks) (P < 0.05) in different fibrosis stages were selected in the modeling group, and multiparameter diagnostic models were established based on changed N-glycan levels by logistic regression analysis. The receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic efficacy of N-glycans models. These models were then compared with the aspartate aminotransferase to platelet ratio index (APRI) , fibrosis index based on the four factors (FIB-4), glutamyltranspeptidase platelet albumin index (S index), GlycoCirrho-test, and GlycoFibro-test. Furthermore, we combined multiparameter diagnostic models with alanine aminotransferase (ALT) and platelet (PLT) tests and compared their diagnostic power. In addition, the diagnostic accuracy of N-glycan models was also verified in the validation group of patients.
RESULTS Multiparameter diagnostic models constructed based on N-glycan peak 1, 3, 4 and 8 could distinguish between different stages of liver fibrosis. The area under ROC curves (AUROCs) of Model A and Model B were 0.890 and 0.752, respectively differentiating fibrosis F0-F1 from F2-F4, and F0-F2 from F3-F4, and surpassing other serum panels. However, AUROC (0.747) in Model C used for the diagnosis of F4 from F0-F3 was lower than AUROC (0.795) in FIB-4. In combination with ALT and PLT, the multiparameter models showed better diagnostic power (AUROC = 0.912, 0.829, 0.885, respectively) when compared with other models. In the validation group, the AUROCs of the three combined models (0.929, 0.858, and 0.867, respectively) were still satisfactory. We also applied the combined models to distinguish adjacent fibrosis stages of 432 patients (F0-F1/F2/F3/F4), and the AUROCs were 0.917, 0.720 and 0.785.
CONCLUSION Multiparameter models based on serum N-glycans are effective supplementary markers to distinguish between adjacent fibrosis stages of patients caused by HBV, especially in combination with ALT and PLT.
Collapse
Affiliation(s)
- Xi Cao
- Department of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China
| | - Qing-Hua Shang
- Department of Liver Disease, No. 88 Hospital of Chinese People’s Liberation Army, Tai'an 271000, Shandong Province, China
| | - Xiao-Ling Chi
- Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, Guangdong Province, China
| | - Wei Zhang
- Department of Liver Disease, No. 88 Hospital of Chinese People’s Liberation Army, Tai'an 271000, Shandong Province, China
| | - Huan-Ming Xiao
- Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, Guangdong Province, China
| | - Mi-Mi Sun
- Department of Liver Disease, No. 88 Hospital of Chinese People’s Liberation Army, Tai'an 271000, Shandong Province, China
| | - Gang Chen
- Department of Liver Disease, No. 88 Hospital of Chinese People’s Liberation Army, Tai'an 271000, Shandong Province, China
| | - Yong An
- Department of Liver Disease, No. 88 Hospital of Chinese People’s Liberation Army, Tai'an 271000, Shandong Province, China
| | - Chun-Lei Lv
- Department of Liver Disease, No. 88 Hospital of Chinese People’s Liberation Army, Tai'an 271000, Shandong Province, China
| | - Lin Wang
- Department of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China
| | - Yue-Min Nan
- Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei Province, China
| | - Cui-Ying Chen
- Department of Molecular Biomedical Research, Xian si-da Biotechnology Company Limited, Nanjing 210000, Jiangsu Province, China
| | - Zong-Nan Tan
- Department of Molecular Biomedical Research, Xian si-da Biotechnology Company Limited, Nanjing 210000, Jiangsu Province, China
| | - Xue-En Liu
- Department of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China
| | - Hui Zhuang
- Department of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China
| |
Collapse
|
4
|
Zhang W, Sun M, Chen G, An Y, Lv C, Wang Y, Shang Q. Reassessment of gamma-glutamyl transpeptidase to platelet ratio (GPR): a large-sample, dynamic study based on liver biopsy in a Chinese population with chronic hepatitis B virus (HBV) infection. Gut 2018; 67:989-991. [PMID: 28814484 PMCID: PMC5890646 DOI: 10.1136/gutjnl-2017-313896] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/03/2017] [Revised: 07/28/2017] [Accepted: 07/29/2017] [Indexed: 12/27/2022]
Affiliation(s)
- Wei Zhang
- Department of Liver Disease, No.88 Hospital of the Chinese People’s Liberation Army, Tai’an, Shandong, China
| | - MiMi Sun
- Department of Liver Disease, No.88 Hospital of the Chinese People’s Liberation Army, Tai’an, Shandong, China
| | - Gang Chen
- Department of Liver Disease, No.88 Hospital of the Chinese People’s Liberation Army, Tai’an, Shandong, China
| | - Yong An
- Department of Liver Disease, No.88 Hospital of the Chinese People’s Liberation Army, Tai’an, Shandong, China
| | - ChunLei Lv
- Department of Liver Disease, No.88 Hospital of the Chinese People’s Liberation Army, Tai’an, Shandong, China
| | - YongQing Wang
- Department of Liver Disease, No.88 Hospital of the Chinese People’s Liberation Army, Tai’an, Shandong, China
| | - QingHua Shang
- Department of Liver Disease, No.88 Hospital of the Chinese People’s Liberation Army, Tai’an, Shandong, China
| |
Collapse
|
5
|
Abstract
BACKGROUNDS Tanshinone IIA (TIIA), a phenanthrenequinone derivative extracted from Salvia miltiorrhiza BUNGE, has been reported to be a natural anti-cancer agent in a variety of tumor cells. However, the effect of TIIA on gastric cancer cells remains unknown. In the present study, we investigated the influence of TIIA on the malignant phenotype of SGC7901 gastric cancer cells. METHODS Cells cultured in vitro were treated with TIIA (0, 1, 5, 10 μg/ml) and after incubation for different periods, cell proliferation was measured by MTT method and cell apoptosis and cell cycling were assessed by flow cytometry (FCM). The sensitivity of SGC7901 gastric cancer cells to anticancer chemotherapy was investigated with the MTT method, while cell migration and invasion were examined by wound-healing and transwell assays, respectively. RESULTS TIIA (1, 5, 10 μg/ml) exerted powerful inhibitory effects on cell proliferation (P < 0.05, and P < 0.01), and this effect was time- and dose-dependent. FCM results showed that TIIA induced apoptosis of SGC7901 cells, reduced the number of cells in S phase and increased those in G0/G1 phase. TIIA also significantly increased the sensitivity of SGC7901 gastric cancer cells to ADR and Fu. Moreover, wound-healing and transwell assays showed that TIIA markedly decreased migratory and invasive abilities of SGC7901 cells. CONCLUSIONS TIIA can reverse the malignant phenotype of SGC7901 gastric cancer cells, indicating that it may be a promising therapeutic agent.
Collapse
Affiliation(s)
- Min Xu
- The 88th Hospital of PLA, Taian, China
| | | | | | | | | | | |
Collapse
|
6
|
Wang PY, Gong HT, Li BF, Lv CL, Wang HT, Zhou HH, Li XX, Xie SY, Jiang BF. Higher expression of circulating miR-182 as a novel biomarker for breast cancer. Oncol Lett 2013; 6:1681-1686. [PMID: 24260062 PMCID: PMC3834356 DOI: 10.3892/ol.2013.1593] [Citation(s) in RCA: 61] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2013] [Accepted: 09/09/2013] [Indexed: 01/07/2023] Open
Abstract
MicroRNAs (miRNAs), present in the serum in a stable and reproducible manner, may be used as biomarkers for various diseases. Few studies have previously investigated circulating miRNAs in the peripheral blood of breast cancer (BC) patients. To identify the role of serum miR-182 levels in BC, the present study detected miR-182 levels in the serum of 46 BC patients and 58 controls, by quantitative PCR. The results showed that the serum miR-182 levels in BC patients were significantly higher compared with the serum of healthy controls (P<0.01). The miR-182 was also overexpressed in the BC tissues compared with the para-carcinoma tissues. Furthermore, the serum levels of miR-182 in the estrogen receptor (ER)-positive patients were considerably lower compared with those in the ER-negative patients. The serum levels of miR-182 in the progesterone receptor (PR)-positive patients were also found to be lower compared with those in the PR-negative patients. The current study highlights results consistent with miR-182 as a novel and valuable biomarker for the diagnosis of BC.
Collapse
Affiliation(s)
- Ping-Yu Wang
- School of Public Health, Shandong University, Jinan, Shandong 250012, P.R. China ; Key Laboratory of Tumour Molecular Biology in Binzhou Medical University, Department of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, Shandong 264003, P.R. China
| | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Lv CL, Chen JH, Zhang YZ, Lu DQ, Ouyang PK. (4R*,5R*)-Diethyl 2-(4-nitro-phen-yl)-1,3-dioxolane-4,5-dicarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online 2012; 68:o1128. [PMID: 22589983 PMCID: PMC3344074 DOI: 10.1107/s160053681201118x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2012] [Accepted: 03/14/2012] [Indexed: 11/16/2022]
Abstract
In the title compound, C15H17NO8, the nitro group is essentially coplanar with the aromatic ring [dihedral angle = 6.4 (3) Å]. The five-membered ring has a twist conformation. In the crystal, C—H⋯O interactions link the molecules into a helical chain propagating along [010].
Collapse
|
8
|
Lv CL, Chen JH, Zhang YZ, Lu DQ, OuYang PK. (4 R*,5 R*)-2-(4-Methoxyphenyl)-1,3-dioxolane-4,5-dicarboxamide. Acta Crystallogr Sect E Struct Rep Online 2012; 68:o558. [PMID: 22412479 PMCID: PMC3297289 DOI: 10.1107/s1600536812002401] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2012] [Accepted: 01/19/2012] [Indexed: 11/11/2022]
Abstract
In the title compound, C12H14N2O5, the five-membered 1,3-dioxolane ring has a twisted conformation. In the crystal, N—H⋯O and C—H⋯O hydrogen bonds link the molecules into a two-dimensional network lying parallel to the ab plane. There are also C—H⋯π interactions present in the crystal structure.
Collapse
|